Company Name: uniQure N.V.
uniQure N.V. is engaged in gene therapy. The company’s initial focus is on the development of gene therapies designed to treat rare diseases. Additionally, the company has a strategic partnership to develop gene therapies for cardiovascular diseases with Bristol-Myers Squibb.
Ticker Symbol: QURE (NASDAQ)
Company Website: www.uniqure.com
Social Media: UniQure LinkedIn
Headquarters: Amsterdam, the Netherlands